Molecular Templates (MTEM) announced the appointment of Maurizio Voi to the role of chief medical officer. Voi possesses more than 35 years of wide-ranging drug development experience. Voi will begin his new role on October 2. Voi joins MTEM from Novartis (NVS), where he served as VP, global program head, for the PD-1 antibody Tislelizumab since April 2021.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on MTEM:
- Molecular Templates Announces the Appointment of Dr. Maurizio Voi to the Role of Chief Medical Officer
- Molecular Templates Announces 1-for-15 Reverse Stock Split
- Molecular Templates announces 1-for-15 reverse stock split
- Molecular Templates files to sell 42.59M shares of common stock for holders
- Molecular Templates announces upcoming milestones
